MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer

Cell Death & Disease
Nana LiLi Jia

Abstract

Accumulating evidences have revealed that dysregulated microRNAs (miRNAs) involve in the tumorigenesis, progression and even lead to poor prognosis of various carcinomas, including breast cancer. MiRNA-106b-5p (miR-106b) and miRNA-93-5p (miR-93) levels were confirmed to be significantly upregulated in breast cancer clinical samples (n=36) and metastatic cell line (MDA-MB-231) compared with those in the paired adjacent tissues and normal breast epithelial cell line (MCF-10A). Moreover, further research stated that the capability of migration, invasion and proliferation changed along with the altered expression of miR-106b and miR-93 in breast cancer. PTEN, the tumor-suppressor gene, was discovered to be reduced in breast cancer tissues or MDA-MB-231 cells with high levels of miR-106b and miR-93, which were inversely expressed in PTEN overexpression tissues or cells. Based on the investigation, miR-106b and miR-93 induced the migration, invasion and proliferation and simultaneously enhanced the activity of phosphatidylinositol-3 kinase (PI3K)/Akt pathway of MCF-7 cells, which could be blocked by upregulation of PTEN. Furthermore, suppression of PTEN reversed the function induced by anti-miR-106b and anti-miR-93 in MDA-MB-231 cell...Continue Reading

References

Jul 17, 2001·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·P L DepowskiJ S Ross
Jun 11, 2002·Human Pathology·Shikha BoseRamon Parsons
Jun 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sudipto DasWonhwa Cho
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Francisca VazquezPeter N Devreotes
Jul 3, 2007·Cell·Brendan D Manning, Lewis C Cantley
Nov 10, 2007·Nucleic Acids Research·Sam Griffiths-JonesAnton J Enright
Feb 25, 2009·Cell Research·Hailong WuYin-Yuan Mo
Oct 5, 2011·CA: a Cancer Journal for Clinicians·Carol DeSantisAhmedin Jemal
Nov 1, 2012·Cell Cycle·Ling FangBurton B Yang
Dec 18, 2012·The Journal of Clinical Investigation·Molly A TaylorWilliam P Schiemann
Feb 26, 2013·The Journal of Clinical Investigation·Rachana PatelHing Y Leung
Mar 16, 2013·Carcinogenesis·Bhupendra SinghHari K Bhat
Apr 17, 2014·Cancer Letters·Wei Hong, Erdan Dong
May 30, 2014·The Lancet Oncology·Lei FanPaul E Goss
Sep 23, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jinhua HuDemin Jiao
Oct 14, 2014·International Journal of Oncology·Xiyan XiaoYanping Zhang
Oct 21, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yanyan LiYongfu Zhao
Aug 5, 2015·Journal of Translational Medicine·Lin ZhengXuenong Li
Dec 19, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Guodong LiFeng Gao
Feb 26, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yue LiX F Steven Zheng
Jun 15, 2016·World Journal of Gastroenterology : WJG·Chia-Sheng YenChia-Jui Yen

❮ Previous
Next ❯

Citations

Dec 28, 2017·International Journal of Molecular Sciences·Dinh-Duc Nguyen, Suhwan Chang
Jan 4, 2019·Journal of Cellular Physiology·Homa MollaeiZeinab Rostami
Dec 17, 2019·Antioxidants & Redox Signaling·Jia Yu LeungReshma Taneja
Jan 4, 2020·European Journal of Cancer Care·Vanessa InnaoCaterina Musolino
Jan 14, 2020·Molecular Oncology·Carmen Griñán-LisónJuan Antonio Marchal
Dec 25, 2019·Cold Spring Harbor Perspectives in Medicine·Erin SellarsLeonardo Salmena
Apr 21, 2020·Cancer Science·Naoki ShibuyaYohei Shimono
Jul 7, 2020·Cell Biochemistry and Function·Jia-Hui GuoFeng-Hou Gao
Jul 31, 2020·Journal of Biochemical and Molecular Toxicology·Fatma AbdallaHari K Bhat
May 18, 2020·Cancer Biomarkers : Section a of Disease Markers·Lina HanShulun Sun
Jul 1, 2020·Stem Cells·James M W R McElhinneyAbdulrahim A Sajini
Sep 8, 2020·Cancer Biomarkers : Section a of Disease Markers·Xuan ZouWei Zhu
Sep 12, 2017·Annals of the New York Academy of Sciences·Do-Hee KimHye-Kyung Na
Jul 27, 2018·Gastroenterology Research and Practice·Shiyuan WangHuirong Liu
Jun 15, 2019·Journal of Experimental & Clinical Cancer Research : CR·Xue GaoLianhong Li
Oct 27, 2017·Molecular Carcinogenesis·Martha L SlatteryJennifer S Herrick
Oct 1, 2019·Technology in Cancer Research & Treatment·Hong LiZilin Li
Apr 26, 2020·Molecular Biology Reports·Ningni JiangJuan Peng
Apr 12, 2020·Cancers·Shahzad Nawaz Syed, Bernhard Brüne
Nov 2, 2019·Journal of Cellular Physiology·Tao XuShu-Kui Wang
Jul 31, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Z WuJ Jin
Jul 3, 2020·Cancer Cell International·Milad AshrafizadehSaeed Samarghandian

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
xenograft
PCR
surgical resections
fluorescence microscopy

Software Mentioned

Ipwin
TargetScan Human
ImageQuant
Image
Pro plus

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.